Bhukya Vijay Nayak

Employment

• Novartis Healthcare Pvt Ltd Senior Scientist
  2020 - Present
• Optimus Pharma.PVT.Ltd Deputy Manager
  2018 - 2020
• Aurobindo Pharma Ltd Research Associate-IV
  2015 - 2018
• Sun Pharma Research Scientist
  2012 - 2015
• Albany Molecular Research Incorporation Research Scientist
  2011 - 2012

Education

• Gandhi Institute of Technology and Management Ph.D Scholar
  2020 - Present
• National Institute of Pharmaceutical Education and Research Hyderabad M.S.
  2009 - 2011
• Osmania University B.Pharmacy
  2005 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Stability indicating RP‐HPLC method development and validation for quantification of impurities in gonadotropin‐releasing hormone (Elagolix): Robustness study by quality by design
  Biomedical Chromatography 2024 DOI: 10.1002/bmc.6036
  +Save
• Implementation of green analytical principles to develop and validate the HPLC method for the separation and identification of degradation products of Panobinostat, and its characterization by using LC-QTOF-MS/MS and its in-silico toxicity prediction usi…
  Green Analytical Chemistry 2024 DOI: 10.1016/j.greeac.2023.100090
  +Save
• Combined green analytical principles and quality by design for ultraperformance liquid chromatography analytical method development, the characterization and in-silico toxicity predictionof Ixazomib degradation products using mass spectrometry
  Green Analytical Chemistry 2024 DOI: 10.1016/j.greeac.2024.100105
  +Save
• Heptad Green Metrics and Quality by Design Tool Evaluated UPLC Content Determination Method for Bexagliflozin in Formulation Product
  SSRN 2024 DOI: 10.2139/ssrn.4726796
  +Save
• Characterization of Prasugrel Degradation Profile by Several Oxidative Reagents using HPLC and LC-MS/MS Technique
  Asian Journal of Chemistry 2023 DOI: 10.14233/ajchem.2024.30710
  +Save
• A CASE REPORT ON FENOFIBRATE AND ATORVASTATIN INDUCED – RHABDOMYOLYSIS
  European Chemical Bulletin 2023
  +Save
• The simultaneous quantification of Sitagliptin and Irbesartan in rat plasma using the validated LC-MS/MS method is applied to a pharmacokinetic study
  Journal of Chromatography B 2023 DOI: 10.1016/j.jchromb.2023.123677
  +Save
• Evaluation Of Efficacy Of SGLT 2 Inhibitors In Diabetic Nephropathy
  Journal of Pharmaceutical Negative Results 2022
  +Save